PMID- 32891689 OWN - NLM STAT- MEDLINE DCOM- 20210125 LR - 20210125 IS - 1872-8227 (Electronic) IS - 0168-8227 (Linking) VI - 169 DP - 2020 Nov TI - Reduced minimum rim width of optic nerve head: a potential early marker of retinal neurodegeneration in children and adolescents with type 1 diabetes. PG - 108420 LID - S0168-8227(20)30673-2 [pii] LID - 10.1016/j.diabres.2020.108420 [doi] AB - AIMS: To determine whether early retinal neurodegenerative changes in pediatric patients with type 1 diabetes (T1D) can be detected by spectral domain-optical coherence tomography (SD-OCT) and whether such changes are associated with risk factors for T1D complications. METHODS: A total of 147 T1D children/adolescents and 51 healthy controls underwent SD-OCT. Spherical refractive error (SRE), macular total retinal thickness (TRT), ganglion cell layer (GCL), retinal nerve fiber layer (RNFL), minimum rim width (MRW), and Bruch's membrane opening area (BMOA) were measured. Clinical and biochemical parameters were recorded at the time of SD-OCT and starting at T1D onset. Multiple regression models were calculated using SD-OCT parameters as dependent and risk factors as independent variables. RESULTS: MRW was significantly thinner in the T1D patients (global MRW:361.58vs386.33 microm; p = 0.009), while RNFL and macular parameters were similar for both groups. MRW was inversely correlated with mean HbA1c (r >/= -0.180, p < 0.05). Multiple regression showed that part of the variability in MRW was explained by HbA1c and BMOA (R(2) = 0.21; p < 0.001), independent of other cardiometabolic risk factors. CONCLUSIONS: MRW reduction could be a potential early marker of retinal neurodegeneration detectable in pediatric patients with T1D. The association between MRW and mean HbA1c suggests that glucometabolic control may affect early retinal neurodegeneration starting in childhood. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Piona, Claudia AU - Piona C AD - Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital of Verona, P.le Stefani 1, 37126 Verona, Italy. Electronic address: claudia.piona@univr.it. FAU - Cozzini, Tiziano AU - Cozzini T AD - Department of Neuroscience, Biomedicine and Movement Sciences, Eye Clinic, University of Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. FAU - Marchini, Giorgio AU - Marchini G AD - Department of Neuroscience, Biomedicine and Movement Sciences, Eye Clinic, University of Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. FAU - Merz, Tommaso AU - Merz T AD - Department of Neuroscience, Biomedicine and Movement Sciences, Eye Clinic, University of Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. FAU - Brighenti, Tommaso AU - Brighenti T AD - Department of Neuroscience, Biomedicine and Movement Sciences, Eye Clinic, University of Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. FAU - Mazzo, Umberto AU - Mazzo U AD - Department of Neuroscience, Biomedicine and Movement Sciences, Eye Clinic, University of Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. FAU - Marigliano, Marco AU - Marigliano M AD - Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital of Verona, P.le Stefani 1, 37126 Verona, Italy. FAU - Olivieri, Francesca AU - Olivieri F AD - Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital of Verona, P.le Stefani 1, 37126 Verona, Italy. FAU - Pedrotti, Emilio AU - Pedrotti E AD - Department of Neuroscience, Biomedicine and Movement Sciences, Eye Clinic, University of Verona, P.le L. A. Scuro 10, 37134 Verona, Italy. FAU - Maffeis, Claudio AU - Maffeis C AD - Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital of Verona, P.le Stefani 1, 37126 Verona, Italy. Electronic address: claudio.maffeis@univr.it. LA - eng PT - Journal Article DEP - 20200904 PL - Ireland TA - Diabetes Res Clin Pract JT - Diabetes research and clinical practice JID - 8508335 SB - IM MH - Adolescent MH - Case-Control Studies MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 1/*complications MH - Female MH - Humans MH - Male MH - Optic Nerve/*abnormalities MH - Retina/*pathology MH - Retinal Degeneration/*pathology OTO - NOTNLM OT - Diabetic retinopathy OT - Minimal neuroretinal rim width OT - Retinal neurodegeneration OT - Spectral domain optical coherence tomography OT - Type 1 Diabetes EDAT- 2020/09/07 06:00 MHDA- 2021/01/26 06:00 CRDT- 2020/09/06 20:24 PHST- 2020/07/07 00:00 [received] PHST- 2020/08/21 00:00 [revised] PHST- 2020/08/29 00:00 [accepted] PHST- 2020/09/07 06:00 [pubmed] PHST- 2021/01/26 06:00 [medline] PHST- 2020/09/06 20:24 [entrez] AID - S0168-8227(20)30673-2 [pii] AID - 10.1016/j.diabres.2020.108420 [doi] PST - ppublish SO - Diabetes Res Clin Pract. 2020 Nov;169:108420. doi: 10.1016/j.diabres.2020.108420. Epub 2020 Sep 4.